3-iodobenzylguanidine has been researched along with Neoplasm Metastasis, Unknown Primary in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ash, S; Bar Shalom, R; Bar-Deroma, R; Ben Barak, A; Berniger, A; Golan, H; Goldstein, G; Houri, H; Kuten, A; Nevelsky, A; Nevo, N; Toren, A; Waldman, D; Weyl Ben-Arush, M; Yaniv, I | 1 |
| Servaes, S; Zhang, W; Zhuang, H | 1 |
| Boot, H; Hoefnageli, CA; Taal, BG; Valdés Olmos, RA; Zuetenhorst, JM | 1 |
| Bussy, E; Jacob, T; Lescout, JM | 1 |
| Arndt, JW; Jeurissen, F; Kagie, MJ; van Luijk, IF | 1 |
| Bagni, B; Orsolon, P | 1 |
1 trial(s) available for 3-iodobenzylguanidine and Neoplasm Metastasis, Unknown Primary
| Article | Year |
|---|---|
Evaluation of (111)In-pentetreotide, (131)I-MIBG and bone scintigraphy in the detection and clinical management of bone metastases in carcinoid disease.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Appendiceal Neoplasms; Bone Neoplasms; Carcinoid Tumor; False Negative Reactions; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms, Unknown Primary; Octreotide; Radiography; Radionuclide Imaging; Radiopharmaceuticals; Rectal Neoplasms; Technetium Tc 99m Medronate | 2002 |
5 other study(ies) available for 3-iodobenzylguanidine and Neoplasm Metastasis, Unknown Primary
| Article | Year |
|---|---|
Targeted therapy with low doses of 131I-MIBG is effective for disease palliation in highly refractory neuroblastoma.
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Bone Neoplasms; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Delivery Systems; Female; Follow-Up Studies; Humans; Infant; Male; Neoplasm Staging; Neoplasms, Unknown Primary; Neuroblastoma; Palliative Care; Retrospective Studies; Treatment Outcome | 2013 |
Abnormal FDG and MIBG Activity in the Bones in a Patient With Neuroblastoma Without Detectable Primary Tumor.
Topics: 3-Iodobenzylguanidine; Bone Neoplasms; Child, Preschool; Fluorodeoxyglucose F18; Humans; Male; Neoplasms, Unknown Primary; Neuroblastoma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2016 |
Malignant diaphragmatic pheochromocytoma.
Topics: 3-Iodobenzylguanidine; Adult; Diaphragm; Humans; Liver Neoplasms; Male; Neoplasms, Unknown Primary; Pheochromocytoma; Postoperative Care; Radiography; Radionuclide Imaging; Radiopharmaceuticals; Thoracic Neoplasms | 2002 |
Intraoperative detection of carcinoid tumor of the ovary by gamma probe.
Topics: 3-Iodobenzylguanidine; Adult; Carcinoid Tumor; Female; Gamma Cameras; Gynecologic Surgical Procedures; Humans; Intraoperative Care; Neoplasms, Unknown Primary; Ovarian Neoplasms; Radionuclide Imaging; Radiopharmaceuticals | 2004 |
131I MIBG/111In octreotide mismatch in a patient with liver metastases secondary to a carcinoid of unknown origin.
Topics: 3-Iodobenzylguanidine; Adult; Contrast Media; Humans; Indium Radioisotopes; Iodine Radioisotopes; Iodobenzenes; Liver Neoplasms; Male; Neoplasms, Unknown Primary; Octreotide; Tomography, Emission-Computed | 1995 |